View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United Kingdom |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2035-04-15 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 750.00 |
| Coupon | 4.875 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 750.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Glaxosmithkline Capital Inc corporate note has a 4.88% fixed rate coupon paid on a semi-annual basis. It was issued on March 13, 2025 with an issue size of 750.00 million USD and matures on April 15, 2035 with a last coupon date of October 15, 2034. |
GlaxoSmithKline Capital Inc, founded in 2000 and headquartered in London, UK, serves as the financing arm of the global healthcare company GlaxoSmithKline plc. The company focuses on providing capital to support its parent’s extensive pharmaceutical and consumer healthcare product lines.